Amaysim Australia Announced A Successful Completion Of Its Institutional Entitlement Offer

Amaysim Australia Announced A Successful Completion Of Its Institutional Entitlement Offer

Shares of Amaysim Australia Limited (ASX: AYS) opened 8.46% down on ASX today. The company announced the successful placement of the institutional component of Institutional Entitlement Offer.

It is to be noted that, the shares are trading after two days of trading halt, upon the request placed by the company on 26th February 2019. The company had requested a trading halt on the ASX, invoking listing rule 17.1, and the company required this in connection to the Institutional Entitlement Offer.  [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

AYS reported that approximately 97% of the Institutional Entitlement has been taken up. This signifies strong participation by the existing eligible institutional shareholders. The company also reported that the institutional bookbuild for entitlements either not taken up by eligible institutional shareholders, or attributable to ineligible institutional and ineligible retail shareholders, witnessed bids significantly exceeding the available bookbuild securities.

The company had earlier stated that the largest shareholder Langfrist (A holder of 16.14% of Amaysim shares) had committed to take-up 100% of its entitlement and provide sub-underwriting support to the Entitlement Offer.

The company raised approximately $35.1 million through an issue of ~58.5 million new shares at $0.60 a share. The offer was made at a discount of 29.1% to TERP (Theoretical ex-rights price) ($0.846 per share)

The CEO and Managing director, Peter O’Connell saw this as a strong display of support from the existing shareholders.

The company in its announcement on 26th February stated that it intended to use the money raised via the offer to:

  • Repay senior debt.
  • Fund working capital/growth capital and.
  • Meet transaction costs.

The new shares issued will rank equally with the existing shares and to be allocated on 7th March 2019, and their trading will commence on a normal settlement basis on the Australian Securities Exchange (“ASX”) on the same day.

The company is further raising $15.5 million via the Retail Entitlement Offer, through a 1 for 2.5 non -renounceable entitlement offer of approximately 25.8 million shares. Eligible retail shareholders on the record date of 7:00 PM Thursday,28 February 2019 (Sydney Time), have the opportunity to apply for the shares at the offer price. The offer will open on Tuesday,5 March 2019 and close at 5:00 PM (Sydney time) on Monday,25 March 2019.

The company in its Entitlement Offer announcement stated that the Independent, Non-Executive Director Thorsten Kraemer had committed to take-up 100% of his entitlement and provide sub-underwriting support for up to a further one million shares to the Retail Entitlement Offer. The participation by the independent director should help build confidence for retail participation.

The Retail Information Booklet, containing the terms and conditions, is expected to be lodged with the ASX and dispatched to the eligible retail shareholders on Tuesday, 5 March 2019.

Stock Information:

AYS share price was down by 12.169% (as at Thu 28 Feb19 3:15 PM) on the ASX. The share price has dropped by around 5.97% in the last six months.

Amaysim Australia Limited’s (ASX: AYS) market capitalization stands at $199.2 million. The Stock has noted the 52-week low price of A$ 0.627 and the 52-week high price of A$1.411. The company has a PE of 72.690 and EPS of 0.013 AUD.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report